Conditions: Inflammation Pain
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 407
Healthy volunteers: no

Brief summary:
This study is being conducted to compare the safety and efficacy of loteprednol etabonate to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.

Detailed description:

Arms:
arm 1: Loteprednol etabonate 0.5% ophthalmic suspension arm 2: Vehicle of loteprednol etabonate ophthalmic suspension

Interventions: intervention 1: Loteprednol etabonate intervention 2: Vehicle of Loteprednol Etabonate
Intervention descriptions: intervention 1: Topical administration of loteprednol etabonate ophthalmic suspension 1-2 drops in study eye four times a day (QID), postoperative day 1-14. intervention 2: Topical administration of vehicle of loteprednol etabonate ophthalmic suspension 1-2 drops in study eye QID, postoperative day 1-14.

Protocol document: